Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery

Claim 2

A thermodynamic therapy system, comprising: a thermally activated drug delivery system which is provided within the bloodstream of a patient under therapy, said thermally activated drug delivery system comprising thermosensitive liposomes; and an adaptive phased array radiation transmission system operable for transmitting and focusing radiation to heat a treatment area within said patient, said adaptive phased array radiation transmission system including a fast acceleration gradient search algorithm to transmit and focus radiation, wherein said drug delivery system releases a selected drug at said treatment area in response to said treatment area being heated by said focused radiation.

Claim 3

The system of claim 1, wherein said thermosensitive liposomes encapsulate a desired pharmaceutical agent.

Claim 4

The system of claim 2, wherein said pharmaceutical agent comprises a chemotherapy agent.

Claim 5

The system of claim 2, wherein said pharmaceutical agent comprises a gene therapy agent.

Claim 6

The system of claim 2, wherein said thermosensitive liposomes undergo a phase transition at a predetermined temperature in order to release said pharmaceutical agents.

Claim 7

The system of claim 1, wherein said adaptive phased array radiation transmission system comprises: means for transmitting radiation; means for controlling the phase and amplitude of said radiation in response to feedback signals; means for detecting said radiation; and control means for receiving the detected radiation and generating said feedback signals, said control means further operable for adjusting said feedback signals in accordance with the detected radiation.

Claim 8

The system of claim 6, wherein said detecting means comprises a plurality of radiation probes disposed non-invasively along the skin surface of said patient.

Claim 9

The system of claim 7, wherein said control means adjusts said feedback signals so that the detected radiation is minimized at said plurality of probes.

Claim 10

The system of claim 8, wherein said control means performs said fast acceleration gradient search algorithm to generate said feedback signals.

Claim 11

The system of claim 9, wherein said control means comprises: means for receiving said radiation from at least an nth field radiator at an ith probe for a jth configuration of transmit weights w nj ; means for calculating a figure of merit F j rec from the received radiation given by ##EQU16## where N aux is the number of probes; means for dithering the transmit weights w nj by a small amount in amplitude, ΔA nj , and phase, ΔΦ nj ; means for determining the figure of merit differences ΔF Anj and ΔF.sub.Φ nj caused by dithering the amplitude and phase, respectively; means for determining gradient search directions r Anj and r.sub.Φnj given by ##EQU17## respectively; and means for generating a new transmit weight w n ,(j+1),k for the (j+1)th configuration and for sub-iterations k, where k=1,2,3, . . . , where the amplitude component of the new weight for the current jth configuration is given by A.sub.n,j,k =A.sub.nj +ΔA.sub.nj r.sub.Anj 2.sup.k-1 and the phase component of the new weight is given by Φ.sub.n,j,k =Φ.sub.nj +ΔΦ.sub.nj r.sub.Φnj 2.sup.k-1.

Claim 12

The system of claim 6, wherein said detecting means comprises an radiation probe disposed at the desired focus of said transmission system.

Claim 13

The system of claim 11, wherein said control means adjusts said feedback signals so that the detected radiation is maximized at said probe.

Claim 14

The system of claim 1, wherein said radiation comprises electromagnetic radiation.

Claim 15

The system of claim 1, wherein said radiation comprises ultrasonic radiation.

Claim 18

The method of claim 15, wherein said thermosensitive liposomes encapsulate a desired pharmaceutical agent.

Claim 19

The method of claim 16, wherein said pharmaceutical agent comprises a chemotherapy agent.

Claim 20

The method of claim 16, wherein said pharmaceutical agent comprises a gene therapy agent.

Claim 21

The method of claim 16, wherein said thermosensitive liposomes undergo a phase transition at a predetermined temperature in order to release said pharmaceutical agents.

Claim 22

The method of claim 15, wherein said step of transmitting and focusing further comprises: transmitting radiation; controlling the phase and amplitude of said radiation in response to feedback signals; detecting said radiation by detecting means; receiving the detected radiation; generating said feedback signals; and adjusting said feedback signals in accordance with the detected radiation.

Claim 23

The method of claim 20, wherein said detecting means comprises a plurality of radiation probes disposed non-invasively along the skin surface of said patient.

Claim 24

The method of claim 20, wherein said detecting means comprises an radiation probe disposed at the desired focus of said transmission system.

Claim 25

The method of claim 22 further comprising adjusting said feedback signals so that the detected radiation is maximized at said probe.

Claim 26

The method of claim 21 further comprising adjusting said feedback signals so that the detected radiation is minimized at said plurality of probes.

Claim 27

The method of claim 24 further comprising performing said fast acceleration gradient search algorithm to generate said feedback signals.

Claim 28

The method of claim 25 further comprising: receiving said radiation from at least an nth field radiator at an ith probe for a jth configuration of transmit weights w nj ; calculating a figure of merit F j rec from the received radiation given by ##EQU18## where N aux is the number of probes; dithering the transmit weights w nj by a small amount in amplitude, ΔA nj , and phase, ΔΦ nj ; determining the figure of merit differences ΔF Anj and ΔF.sub.Φnj caused by dithering the amplitude and phase, respectively; determining gradient search directions r Anj and r.sub.Φnj given by ##EQU19## respectively; and generating a new transmit weight w n ,(j+1),k for the (j+1)th configuration and for sub-iterations k, where K=1,2,3, . . . , where the amplitude component of the new weight for the current jth configuration is given by A.sub.n,j,k =A.sub.nj +ΔA.sub.nj r.sub.Anj 2.sup.k-1 and the phase component of the new weight is given by Φ.sub.n,j,k =Φ.sub.nj +ΔΦ.sub.nj r.sub.Φnj 2.sup.k-1.

Claim 29

The method of claim 15, wherein said radiation comprises electromagnetic radiation.

Claim 30

The method of claim 15, wherein said radiation comprises ultrasonic radiation.